Literature DB >> 28373632

Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms.

Koichi Tsuneyama1, Hayato Baba, Yuki Morimoto, Takaaki Tsunematsu, Hirohisa Ogawa.   

Abstract

Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is an organ-specific autoimmune disease that predominantly affects middle-aged women and is characterized by the chronic progressive destruction of small intrahepatic bile ducts with portal inflammation and, ultimately, fibrosis. The serological hallmark of PBC is the presence of anti-mitochondrial autoantibodies (AMA). Several mechanisms have been proposed for immune-mediated bile duct damage in PBC, including the roles of T cells, B cells, other cell phenotypes, and AMA. A sign of fragility of biliary epithelial cells caused by apoptosis, senescence, and autophagy has also been noted. Several complex steps and mechanisms appear to be involved in the induction and progression of cholangitis and biliary degeneration in patients with PBC. J. Med. Invest. 64: 7-13, February, 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28373632     DOI: 10.2152/jmi.64.7

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  19 in total

Review 1.  The Contribution of B Cells in Autoimmune Liver Diseases.

Authors:  Sarah A Taylor; David N Assis; Cara L Mack
Journal:  Semin Liver Dis       Date:  2019-06-21       Impact factor: 6.115

Review 2.  Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Lindsey Kennedy; Suthat Liangpunsakul; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2019-04-22       Impact factor: 6.902

3.  Intravital imaging reveals inflammation as a dominant pathophysiology of age-related hepatovascular changes.

Authors:  Ravi Vats; Ziming Li; Eun-Mi Ju; Rikesh K Dubey; Tomasz W Kaminski; Simon Watkins; Tirthadipa Pradhan-Sundd
Journal:  Am J Physiol Cell Physiol       Date:  2022-01-05       Impact factor: 4.249

4.  Investigation of immune complexes formed by mitochondrial antigens containing a new lipoylated site in sera of primary biliary cholangitis patients.

Authors:  N Aibara; K Ohyama; M Nakamura; H Nakamura; M Tamai; N Kishikawa; A Kawakami; K Tsukamoto; M Nakashima; N Kuroda
Journal:  Clin Exp Immunol       Date:  2021-03-22       Impact factor: 5.732

5.  Detection of Anti-mitochondrial Antibodies Accompanied by Drug-induced Hepatic Injury due to Atorvastatin.

Authors:  Noriyuki Kuniyoshi; Hiroshi Miyakawa; Kotaro Matsumoto; Hiromichi Tsunashima; Katsunori Sekine; Takayuki Tsujikawa; Masatoshi Mabuchi; Shinpei Doi; Kentaro Kikuchi
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

Review 6.  Aging-Related Molecular Pathways in Chronic Cholestatic Conditions.

Authors:  Claudio Pinto; Elisabetta Ninfole; Antonio Benedetti; Luca Maroni; Marco Marzioni
Journal:  Front Med (Lausanne)       Date:  2020-01-21

7.  Changes of Serum IgG Glycosylation Patterns in Primary Biliary Cholangitis Patients.

Authors:  Xiaoli Zeng; Siting Li; Shiyi Tang; Xi Li; Guoyuan Zhang; Mengtao Li; Xiaofeng Zeng; Chaojun Hu
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

Review 8.  Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.

Authors:  Samantha Sarcognato; Diana Sacchi; Federica Grillo; Nora Cazzagon; Luca Fabris; Massimiliano Cadamuro; Ivana Cataldo; Claudia Covelli; Alessandra Mangia; Maria Guido
Journal:  Pathologica       Date:  2021-06

Review 9.  Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis.

Authors:  Aleksandar Arsenijevic; C Randall Harrell; Crissy Fellabaum; Vladislav Volarevic
Journal:  Anal Cell Pathol (Amst)       Date:  2017-12-19       Impact factor: 2.916

10.  Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis.

Authors:  Mona L Martin; Larissa Stassek; Steven I Blum; Ashish V Joshi; David Jones
Journal:  J Patient Rep Outcomes       Date:  2019-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.